Effect of Coolsense device and EMLA cream on pain during intravenous cannulation in children

Effect of coolsense and emla cream on pain during intravenous cannulation in paediatric population- A randomised controlled trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/03/018001

Enrollment

140

Registered

2019-03-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: CoolSense device: CoolSense device reduces the skin temperature and paralyses the nerve sensation for several seconds such that pain on intravenous cannulation is reduced. It will be ap

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 and 2

Exclusion criteria

Exclusion criteria: Premedicated children History of skin allergies Who demonstrate the inability to understand the questionnaire Children with known anxiety disorder Use of analgesics in the past 24hrs Patient or their parent/guardian refusal

Design outcomes

Primary

Measure	Time frame
To assess and compare the effects of CoolSense and EMLA cream on pain during IV cannulation in paediatric populationTimepoint: After IV cannulation	—

Secondary

Measure	Time frame
To assess anxiety level in children Successful first attempt cannulation Technical difficulties faced Parent/guardian satisfaction Preference for future useTimepoint: After IV cannulation	—

Countries

India

Contacts

Public ContactPratibha Alice Xess

Postgraduate Institute of Medical Education and Research, Chandigarh

sameersethi29@gmail.com7087008491

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026